Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis
Li, Jing, Wei, Hui, Krystek, Stanley R, Bond, Derek, Brender, Ty M, Cohen, Daniel, Feiner, Jena, Hamacher, Nels, Harshman, Johanna, Huang, Richard Y.-C, Julien, Susan H, Lin, Zheng, Moore, Kristina, Mueller, Luciano, Noriega, Claire, Sejwal, Preeti, Sheppard, Paul, Stevens, Brenda, Chen, Guodong, Tymiak, Adrienne A, Gross, Michael L, Schneeweis, Lumelle A
Published in Analytical chemistry (Washington) (21.02.2017)
Published in Analytical chemistry (Washington) (21.02.2017)
Get full text
Journal Article
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes
Hippen, Keli L., Bucher, Christoph, Schirm, Dawn K., Bearl, Amanda M., Brender, Ty, Mink, Kathy A., Waggie, Kimberly S., Peffault de Latour, Regis, Janin, Anne, Curtsinger, Julie M., Dillon, Stacey R., Miller, Jeffrey S., Socie, Gerard, Blazar, Bruce R.
Published in Blood (12.01.2012)
Published in Blood (12.01.2012)
Get full text
Journal Article
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
Bezman, Natalie A., Jhatakia, Amy, Kearney, Alper Y., Brender, Ty, Maurer, Mark, Henning, Karla, Jenkins, Misty R., Rogers, Amy J., Neeson, Paul J., Korman, Alan J., Robbins, Michael D., Graziano, Robert F.
Published in Blood advances (09.05.2017)
Published in Blood advances (09.05.2017)
Get full text
Journal Article
712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors
Metz, Heather, Brender, Ty, Stevens, Brenda, Winship, Damion, Brevik, Jamie, Comeau, Michael, Childs, Monica, Chang, Jenny, Fan, Li-Qun, Xu, Hengyu, Grey, Jonathan, Adamo, Jeffrey, Setter, Ben, Carrillo, Ray, Smith, Sean, Tan, Phil, DuBose, Robert, Latchman, Yvette, Baum, Peter, Odegard, Valerie
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Abstract 3271: A systemically administered, conditionally active TLR8 agonist for the treatment of HER2-expressing tumors
Moyes, Kara, Brender, Ty, Smith, Sean W., Xu, Hengyu, Setter, Ben, Fan, Li-Qun, Brunette, Rebecca, Killebrew, Justin, Tan, Phil, Coburn, Craig, Baum, Peter, Odegard, Valerie
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 4537: SBT6050, a HER2-directed TLR8 ImmunoTAC™therapeutic, is a potent human myeloid cell agonist that provides opportunity for single agent clinical activity
Comeau, Michael R., Brender, Ty, Childs, Monica, Brevik, Jamie, Winship, Damion, Metz, Heather, Chang, Jenny, Adamo, Jeffrey, Setter, Ben, Xu, Hengyu, Fan, Li-Qun, Stevens, Brenda, Smith, Sean W., Tan, Phil, DuBose, Robert, Latchman, Yvette, Baum, Peter, Odegard, Valerie
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
SBT6050, a HER2-directed TLR8 therapeutic, as a systemically administered, tumor-targeted human myeloid cell agonist
Metz, Heather, Childs, Monica, Brevik, Jamie, Winship, Damion, Brender, Ty, Comeau, Michael, Moyes, Kara, Chang, Jenny, Adamo, Jeffrey, Setter, Ben, Xu, Hengyu, Fan, Li-Qun, Smith, Sean, Tan, Phil, DuBose, Robert, Latchman, Yvette, Baum, Peter, Odegard, Valerie
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract PD4-09: Preclinical studies support the development of SBT6050, an anti-HER2 antibody conjugated to a potent TLR8 agonist, for treatment of moderate and high HER2-expressing tumors that lack pre-existing T cell infiltrate
Odegard, Valerie H, Moyes, Kara, Childs, Monica, Brevik, Jamie, Winship, Damion, Brender, Ty, Metz, Heather, Chang, Jenny R, Adamo, Jeffrey, Setter, Ben, Xu, Hengyu, Fan, Li-Qun, Smith, Sean W, Tan, Phil, DuBose, Robert, Latchman, Yvette, Baum, Peter
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F
Kuestner, Rolf E, Taft, David W, Haran, Aaron, Brandt, Cameron S, Brender, Ty, Lum, Karen, Harder, Brandon, Okada, Shannon, Ostrander, Craig D, Kreindler, James L, Aujla, Shean J, Reardon, Brian, Moore, Margaret, Shea, Pamela, Schreckhise, Randall, Bukowski, Thomas R, Presnell, Scott, Guerra-Lewis, Patricia, Parrish-Novak, Julia, Ellsworth, Jeff L, Jaspers, Stephen, Lewis, Katherine E, Appleby, Mark, Kolls, Jay K, Rixon, Mark, West, James W, Gao, Zeren, Levin, Steven D
Published in Journal of Immunology (15.10.2007)
Published in Journal of Immunology (15.10.2007)
Get full text
Journal Article
Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions
Parrish-Novak, Julia, Xu, Wenfeng, Brender, Ty, Yao, Lena, Jones, Crystal, West, Jim, Brandt, Cameron, Jelinek, Laura, Madden, Karen, McKernan, Patricia A, Foster, Donald C, Jaspers, Stephen, Chandrasekher, Yasmin A
Published in The Journal of biological chemistry (06.12.2002)
Published in The Journal of biological chemistry (06.12.2002)
Get full text
Journal Article
Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes
Parrish-Novak, Julia, Xu, Wenfeng, Brender, Ty, Yao, Lena, Jones, Crystal, West, Jim, Brandt, Cameron, Jelinek, Laura, Madden, Karen, McKernan, Patricia A., Foster, Donald C., Jaspers, Stephen, Chandrasekher, Yasmin A.
Published in The Journal of biological chemistry (06.12.2002)
Published in The Journal of biological chemistry (06.12.2002)
Get full text
Journal Article
Interleukin 20: Discovery, Receptor Identification, and Role in Epidermal Function
Blumberg, Hal, Conklin, Darrell, Xu, WenFeng, Grossmann, Angelika, Brender, Ty, Carollo, Susan, Eagan, Maribeth, Foster, Don, Haldeman, Betty A, Hammond, Angie, Haugen, Harald, Jelinek, Laura, Kelly, James D, Madden, Karen, Maurer, Mark F, Parrish-Novak, Julia, Prunkard, Donna, Sexson, Shannon, Sprecher, Cindy, Waggie, Kim, West, Jim, Whitmore, Theodore E, Yao, Lena, Kuechle, Melanie K, Dale, Beverly A, Chandrasekher, Yasmin A
Published in Cell (12.01.2001)
Published in Cell (12.01.2001)
Get full text
Journal Article
Engineering of stable bispecific antibodies targeting IL-17A and IL-23
Mabry, Robert, Lewis, Katherine E., Moore, Margaret, McKernan, Patricia A., Bukowski, Thomas R., Bontadelli, Kristen, Brender, Ty, Okada, Shannon, Lum, Karen, West, James, Kuijper, Joseph L., Ardourel, Dan, Franke, Secil, Lockwood, Luann, Vu, Tuyen, Frank, Amanda, Appleby, Mark W., Wolf, Anitra, Reardon, Brian, Hamacher, Nels B., Stevens, Brenda, Lewis, Patsy, Lewis, Kenneth B., Gilbertson, Debra G., Lantry, Megan, Julien, Susan H., Ostrander, Craig, Chan, Chung, Byrnes-Blake, Kelly, Brody, Jennifer, Presnell, Scott, Meengs, Brent, Levin, Steven D., Snavely, Mark
Published in Protein engineering, design and selection (01.03.2010)
Published in Protein engineering, design and selection (01.03.2010)
Get full text
Journal Article
A Soluble Class II Cytokine Receptor, IL-22RA2, is a Naturally Occurring IL-22 Antagonist
Xu, Wenfeng, Presnell, Scott R., Parrish-Novak, Julia, Kindsvogel, Wayne, Jaspers, Steve, Chen, Zhi, Dillon, Stacey R., Gao, Zeren, Gilbert, Teresa, Madden, Karen, Schlutsmeyer, Stacy, Yao, Lena, Whitmore, Theodore E., Chandrasekher, Yasmin, Grant, Francis J., Maurer, Mark, Jelinek, Laura, Storey, Harold, Brender, Ty, Hammond, Angie, Topouzis, Stavros, Clegg, Christopher H., Foster, Donald C.
Published in Proceedings of the National Academy of Sciences - PNAS (14.08.2001)
Published in Proceedings of the National Academy of Sciences - PNAS (14.08.2001)
Get full text
Journal Article
Interleukin 20
Blumberg, Hal, Conklin, Darrell, Xu, WenFeng, Grossmann, Angelika, Brender, Ty, Carollo, Susan, Eagan, Maribeth, Foster, Don, Haldeman, Betty A, Hammond, Angie, Haugen, Harald, Jelinek, Laura, Kelly, James D, Madden, Karen, Maurer, Mark F, Parrish-Novak, Julia, Prunkard, Donna, Sexson, Shannon, Sprecher, Cindy, Waggie, Kim, West, Jim, Whitmore, Theodore E, Yao, Lena, Kuechle, Melanie K, Dale, Beverly A, Chandrasekher, Yasmin A
Published in Cell (01.01.2001)
Published in Cell (01.01.2001)
Get full text
Journal Article
TREATMENT OF GRAFT-VERSUS-HOST DISEASE
BYRNES-BLAKE KELLY, UNDERWOOD SARA, HOSKEN NANCY, MOORE MARGARET, RIXON MARK, RENE SHIRLEY, WAGGIE KIMBERLY, HUBER MONICA, BRENDER TY
Year of Publication 15.04.2010
Get full text
Year of Publication 15.04.2010
Patent
TREATMENT OF APLASTIC ANEMIA
HUBER MONICA J, BYRNES-BLAKE KELLY, UNDERWOOD SARA, HOSKEN NANCY, MOORE MARGARET D, RENE SHIRLEY, BRENDER TY, RIXON MARK W
Year of Publication 14.01.2010
Get full text
Year of Publication 14.01.2010
Patent
ANTAGONISTS OF IL-17A, IL-17F, AND IL-23 AND METHODS OF USING THE SAME
GUERRA-LEWIS, PATRICIA, I, LEWIS, KATHERINE, E, YI, EUGENE, C, BRENDER, TY, M, PRESNELL, SCOTT, R, THOMPSON, PENNY, J, MABRY III, GEORGE, ROBERT, MOORE, MARGARET, D, STEVENS, BRENDA, L
Year of Publication 29.10.2009
Get full text
Year of Publication 29.10.2009
Patent
ANTAGONISTS OF IL-17A, IL-17F, AND IL-23 AND METHODS OF USING THE SAME
GUERRA-LEWIS, PATRICIA, I, LEWIS, KATHERINE, E, YI, EUGENE, C, BRENDER, TY, M, PRESNELL, SCOTT, R, THOMPSON, PENNY, J, MABRY III, GEORGE, ROBERT, MOORE, MARGARET, D, STEVENS, BRENDA, L
Year of Publication 02.07.2009
Get full text
Year of Publication 02.07.2009
Patent